StockData
Trinity Biotech PLC logo

Trinity Biotech PLC (TRIB) stock

TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 1/30
$6.01+0.63 (+11.81%)

Close on Nov 17, 2026Market cap $112.45MP/E –Yield –

Trinity Biotech total assets

Total assets on the balance sheet at the end of each period.

Trinity Biotech's total assets was $105.17M at Dec 31, 2025. For fiscal 2025 it was $105.17M, up 1.8% from the year before. The highest annual figure on record is $249.59M in fiscal 2016.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$105.17M+1.8%
FY2024Dec 31, 2024$103.29M+73.8%
FY2023Dec 31, 2023$59.44M-35.5%
FY2022Dec 31, 2022$92.10M-22.5%
FY2021Dec 31, 2021$118.90M-8.8%
FY2020Dec 31, 2020$130.40M-0.5%
FY2019Dec 31, 2019$131.07M-13.6%
FY2018Dec 31, 2018$151.66M-21.4%
FY2017Dec 31, 2017$192.97M-22.7%
FY2016Dec 31, 2016$249.59M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$105.17M+76.9%
Q2 FY2025Jun 30, 2025$99.63M+8.2%
Q4 FY2024Dec 31, 2024$103.29M-3.6%
Q2 FY2024Jun 30, 2024$94.36M-20.6%
Q4 FY2023Dec 31, 2023$59.44M-54.4%
Q4 FY2022Dec 31, 2022$92.10M-29.7%
Q2 FY2022Jun 30, 2022$107.14M-29.4%
Q4 FY2021Dec 31, 2021$118.90M-38.9%
Q4 FY2020Dec 31, 2020$130.40M-33.0%
Q4 FY2019Dec 31, 2019$131.07M-32.1%
Q4 FY2018Dec 31, 2018$151.66M-39.2%
Q2 FY2018Jun 30, 2018$194.45M–
Q1 FY2018Mar 31, 2018$194.68M–
Q4 FY2017Dec 31, 2017$192.97M–
Q4 FY2016Dec 31, 2016$249.59M–

More Trinity Biotech figures

See a number that looks wrong?